InCode BioPharmaceutics
Latest round
- Series A
Last raised
- Jul 2006
Total raised
- $1M
Investors
- 1
About InCode BioPharmaceutics
Founded in 2006 and based in Hawaii, US, InCode BioPharmaceutics, Inc. operates as a biopharmaceutical company that develops immunomodulatory protein for the treatment of inflammatory and autoimmune diseases.
Who invested in InCode BioPharmaceutics
1 investor across 1 round
See all investors in InCode BioPharmaceutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 26, 2006
Amount
$1M
Investors
Questions about InCode BioPharmaceutics
Who invested in InCode BioPharmaceutics?
InCode BioPharmaceutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InCode BioPharmaceutics raised?
InCode BioPharmaceutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did InCode BioPharmaceutics last raise money?
InCode BioPharmaceutics's most recent round on record is a Series A, in Jul 2006.
What does InCode BioPharmaceutics do?
Founded in 2006 and based in Hawaii, US, InCode BioPharmaceutics, Inc.
Where is InCode BioPharmaceutics headquartered?
InCode BioPharmaceutics is headquartered in US.
Which VCs invest in companies like InCode BioPharmaceutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at InCode BioPharmaceutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like InCode BioPharmaceutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.